Whereas generation of tumor cell debris throughout treatment may be an inherent therapeutic limit to current cytotoxic cancer therapies, inhibiting OPN or other mediators of the tumor-promoting activity of cell debris, in combination with cytotoxic treatment, may represent a novel approach to preventing therapy-induced tumor growth and recurrence. Here, SPP1 is linked to cancer.